Trials / Not Yet Recruiting
Not Yet RecruitingNCT07037823
Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis
Effectiveness of the Combination Strategy of Disease-Modifying Therapy and the Yishen Daluo Yin Modified Formula for Multiple Sclerosis: A Prospective Multi-Center Observational Comparative Study
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 328 (estimated)
- Sponsor
- Ying Gao · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to investigate the effectiveness of a combined strategy utilizing disease-modifying therapy and the modified Yishen Daluo Yin formula for relapsing-remitting multiple sclerosis (RRMS) through a prospective, multicenter, observational comparative study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Modified Yishen Daluo Yin formula | The specific application of the modified Yishen Daluo Yin formula, including the starting point, dosage, and duration of treatment, should be determined based on medical advice, the patient's condition, and their individual preferences. |
Timeline
- Start date
- 2025-07-01
- Primary completion
- 2026-10-31
- Completion
- 2026-12-31
- First posted
- 2025-06-26
- Last updated
- 2025-06-26
Source: ClinicalTrials.gov record NCT07037823. Inclusion in this directory is not an endorsement.